The rate of occurrence, healthcare resource use and costs of adverse events among metastatic non-small cell lung cancer patients treated with first- and second-generation epidermal growth factor receptor tyrosine kinase inhibitors

Resource Use ◽

Kinase Inhibitors ◽

Healthcare Resource ◽

Growth Factor Receptor ◽

Healthcare Resource Use ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

First And Second Generation

Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.13878 ◽

2021 ◽

Author(s):

Nobuaki Kobayashi ◽

Seigo Katakura ◽

Chisato Kamimaki ◽

Kohei Somekawa ◽

Nobuhiko Fukuda ◽

...

Keyword(s):

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Resistance Mechanisms ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

P8‐75: First‐ or second‐generation epidermal growth factor receptor tyrosine kinase inhibitors in a large real‐world cohort of non‐small cell lung cancer patients

Respirology ◽

10.1111/resp.14150_587 ◽

2021 ◽

Vol 26 (S3) ◽

pp. 317-317

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

P2-101: Preliminary assessments using nonlinear regression analysis of semilog survival curve plots to detect and characterize prognostically distinct subgroups in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283565.16667.1d ◽

2007 ◽

Vol 2 (8) ◽

pp. S531 ◽

Cited By ~ 1

Author(s):

David J. Stewart

Keyword(s):

Kinase Inhibitors ◽

Survival Curve ◽

Growth Factor Receptor ◽

Small Cell ◽

Nonlinear Regression Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation

Lung Cancer ◽

10.1016/j.lungcan.2012.05.092 ◽

2012 ◽

Vol 77 (3) ◽

pp. 556-560 ◽

Cited By ~ 194

Author(s):

S.J. Park ◽

H.T. Kim ◽

D.H. Lee ◽

K.P. Kim ◽

S.-W. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors ◽

Exon 19

Changes in Plasma Mass-Spectral Profile in Course of Treatment of Non-small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307f17 ◽

2012 ◽

Vol 7 (1) ◽

pp. 40-48 ◽

Cited By ~ 25

Author(s):

Chiara Lazzari ◽

Anna Spreafico ◽

Angela Bachi ◽

Heinrich Roder ◽

Irene Floriani ◽

...

Keyword(s):

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Spectral Profile ◽

Small Cell Lung ◽

Mass Spectral ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in EGFR Mutation; Positive Non-small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318174e981 ◽

2008 ◽

Vol 3 (6) ◽

pp. S143-S145 ◽

Cited By ~ 12

Author(s):

Lecia V. Sequist

Keyword(s):

First Generation ◽

Kinase Inhibitors ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Epidermal growth factor receptor-tyrosine kinase inhibitors for non-small-cell lung cancer patients aged 80 years or older: A retrospective analysis

Molecular and Clinical Oncology ◽

10.3892/mco.2014.453 ◽

2014 ◽

Vol 3 (2) ◽

pp. 403-407 ◽

Cited By ~ 6

Author(s):

MAKOTO NAKAO ◽

HIDEKI MURAMATSU ◽

KAZUKI SONE ◽

SACHIKO AOKI ◽

HARATA AKIKO ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients?

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2012.09.001 ◽

2013 ◽

Vol 39 (5) ◽

pp. 489-497 ◽

Cited By ~ 14

Author(s):

Antonio Rossi ◽

Raffaella Pasquale ◽

Claudia Esposito ◽

Nicola Normanno

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Cancer Research and Treatment ◽

10.4143/crt.2013.120 ◽

2014 ◽

Vol 46 (4) ◽

pp. 323-330 ◽

Cited By ~ 13

Author(s):

Bhumsuk Keam ◽

Dong-Wan Kim ◽

Jin Hyun Park ◽

Jeong-Ok Lee ◽

Tae Min Kim ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutations.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7606 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7606-7606 ◽

Cited By ~ 5

Author(s):

K. Kim ◽

D. H. Lee ◽

J. Lee ◽

C. Suh ◽

S. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Receptor Tyrosine Kinase Inhibitors ◽

Exon 19